| 标题 |
Response to Xing et al.: post-marketing safety concerns with Lecanemab: a pharmacovigilance study based on the FDA adverse event reporting system database |
| 网址 | |
| DOI | |
| 其它 |
期刊:Alzheimer s Research & Therapy 作者:Michael C. Irizarry; Ilona Surick; A. Warhurst Michael; Lynn D. Kramer 出版日期:2025-04-25 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)